Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
This study is currently recruiting participants.
Verified May 2011 by Avila Therapeutics
Study NCT01351935
Information provided by Avila Therapeutics
First Received on May 10, 2011.
Last Updated on September 7, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
